Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-10 | Ms. Silverstein brings 15 years of experience in capital markets strategy, financial services, investor relations and healthcare media communications. |
| 2021-04-09 | Christine Silverstein, 38, became a director in March 2020. |
| 2022-05-12 | Directors and Named Executive Officers: Christine Silverstein |
| 2022-07-11 | Ms. Silverstein has served as Chief Financial Officer of Excision Biotherapeutics, Inc. |
| 2023-04-13 | Christine Silverstein, 40, became a director in March 2020. |
| 2024-03-19 | Christine Silverstein, 41, became a director in March 2020 and currently serves as chair of the Audit Committee. |
| 2024-11-12 | The table below represents the compensation paid to each of our directors who served on the Board during the year ended December 31, 2023. |
Data sourced from SEC filings. Last updated: 2025-07-01